These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6317706)

  • 1. Serotyping of herpes simplex virus isolates: a comparison of BVDU sensitivities, indirect immunofluorescence with monoclonal antibodies, and indirect immunofluorescence with cross-adsorbed rabbit antibodies.
    Sacks SL; Teh CZ; Lemchuk-Favel L
    J Virol Methods; 1983 Oct; 7(4):199-206. PubMed ID: 6317706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and typing of herpes simplex virus types 1 and 2 by monoclonal antibodies, sensitivity to the drug (E)-5-(2-bromovinyl)-2'-deoxyuridine, and restriction endonuclease analysis of viral DNA.
    Zimmerman DH; Mundon FK; Croson SE; Henchal LS; Docherty JJ; O'Neill SP
    J Med Virol; 1985 Mar; 15(3):215-22. PubMed ID: 2984324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of biological, biochemical, immunological, and immunochemical techniques for typing herpes simplex virus isolates.
    Zheng ZM; Mayo DR; Hsiung GD
    J Clin Microbiol; 1983 Mar; 17(3):396-9. PubMed ID: 6302130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Problems associated with the use of (E)-5-(2-bromovinyl)-2'-deoxyuridine for typing herpes simplex virus.
    Swierkosz EM; Arens MQ; Rivetna KA
    J Clin Microbiol; 1985 Mar; 21(3):459-61. PubMed ID: 2984249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of four methods for typing low-passage herpes simplex virus isolates.
    Mayo D; Hilliard J; Landry M; Egbertson S; Mirkovic R
    Intervirology; 1985; 23(2):112-5. PubMed ID: 2984142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herpes simplex virus type 1 that exhibits herpes simplex virus type 2 sensitivity to (E)-5-(2-bromovinyl)-2'-deoxyuridine.
    Docherty JJ; Dobson AT; Trimble JJ; Jennings BA
    Intervirology; 1991; 32(5):308-15. PubMed ID: 1657822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of immunofluorescence with commercial monoclonal antibodies to biochemical and biological techniques for typing clinical herpes simplex virus isolates.
    Balkovic ES; Hsiung GD
    J Clin Microbiol; 1985 Nov; 22(5):870-2. PubMed ID: 2997273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of herpes simplex virus types 1 and 2 by sensitivity to (E)-5-(2-bromovinyl)-2'-deoxyuridine.
    Mayo DR
    J Clin Microbiol; 1982 Apr; 15(4):733-6. PubMed ID: 6279696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Typing of clinical herpes simplex virus isolates with mouse monoclonal antibodies to herpes simplex virus types 1 and 2: comparison with type-specific rabbit antisera and restriction endonuclease analysis of viral DNA.
    Peterson E; Schmidt OW; Goldstein LC; Nowinski RC; Corey L
    J Clin Microbiol; 1983 Jan; 17(1):92-6. PubMed ID: 6298276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and typing of herpes simplex virus by enzyme immunoassay with monoclonal antibodies.
    Frame B; Mahony JB; Balachandran N; Rawls WE; Chernesky MA
    J Clin Microbiol; 1984 Aug; 20(2):162-6. PubMed ID: 6092415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of three immunofluorescence assays for culture confirmation and typing of herpes simplex virus.
    Lipson SM; Schutzbank TE; Szabo K
    J Clin Microbiol; 1987 Feb; 25(2):391-4. PubMed ID: 3029172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of two immunofluorescence assays with monoclonal antibodies for typing of herpes simplex virus.
    Swierkosz EM; Arens MQ; Schmidt RR; Armstrong T
    J Clin Microbiol; 1985 Apr; 21(4):643-4. PubMed ID: 2985651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of three methods for typing herpes simplex virus.
    Salmerón F; Pérez Breña P; Rojas JM; Hernáez Lobo R; Tabarés E
    Eur J Clin Microbiol; 1987 Dec; 6(6):664-7. PubMed ID: 2831045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of monoclonal antibodies to differentiate isolates of herpes simplex types 1 and 2 by neutralisation and reverse passive haemagglutination tests.
    Buckmaster EA; Cranage MP; McLean CS; Coombs RR; Minson A
    J Med Virol; 1984; 13(2):193-202. PubMed ID: 6319591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of oral HSV-2 in a college student population.
    Docherty JJ; Trimble JJ; Roman SR; Faulkner SC; Naugle FP; Mundon FK; Zimmerman DH
    J Med Virol; 1985 Jul; 16(3):283-7. PubMed ID: 2993498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intentional reactivation of latent ocular herpes infection during BVDU therapy.
    Trousdale MD; Robin JB; Willey DE; De Clercq E
    Curr Eye Res; 1987 Dec; 6(12):1471-7. PubMed ID: 2827960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbocyclic 5-iodo-2'-deoxyuridine (C-IDU) and carbocyclic (E)-5-(2-bromovinyl)-2'-deoxyuridine (C-BVDU) as unique examples of chiral molecules where the two enantiomeric forms are biologically active: interaction of the (+)- and (-)-enantiomers of C-IDU and C-BVDU with the thymidine kinase of herpes simplex virus type 1.
    Balzarini J; De Clercq E; Baumgartner H; Bodenteich M; Griengl H
    Mol Pharmacol; 1990 Mar; 37(3):395-401. PubMed ID: 2156153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and related compounds on herpes simplex virus (HSV)-infected cells and HSV thymidine kinase gene-transformed cells.
    Balzarini J; De Clercq E
    Methods Find Exp Clin Pharmacol; 1989 Jun; 11(6):379-89. PubMed ID: 2545982
    [No Abstract]   [Full Text] [Related]  

  • 19. Thymidylate synthase is the principal target enzyme for the cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine against murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 or type 2 thymidine kinase gene.
    Balzarini J; De Clercq E; Verbruggen A; Ayusawa D; Shimizu K; Seno T
    Mol Pharmacol; 1987 Sep; 32(3):410-6. PubMed ID: 2823092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly selective cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine derivatives for murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 thymidine kinase gene.
    Balzarini J; De Clercq E; Verbruggen A; Ayusawa D; Seno T
    Mol Pharmacol; 1985 Dec; 28(6):581-7. PubMed ID: 3001499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.